Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Intra-Uterine Contraceptive Devices Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Intra-Uterine Contraceptive Devices Market Status and Forecast (2016-2027)
      • 1.3.2 Global Intra-Uterine Contraceptive Devices Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Intra-Uterine Contraceptive Devices Supply by Company

    • 2.1 Global Intra-Uterine Contraceptive Devices Sales Volume by Company
    • 2.2 Global Intra-Uterine Contraceptive Devices Sales Value by Company
    • 2.3 Global Intra-Uterine Contraceptive Devices Price by Company
    • 2.4 Intra-Uterine Contraceptive Devices Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Intra-Uterine Contraceptive Devices Market Status by Category

    • 3.1 Intra-Uterine Contraceptive Devices Category Introduction
      • 3.1.1 Copper IUCD
      • 3.1.2 Hormonal IUCD
    • 3.2 Global Intra-Uterine Contraceptive Devices Market by Category
      • 3.2.1 Global Intra-Uterine Contraceptive Devices Sales Volume by Category (2016-2021)
      • 3.2.2 Global Intra-Uterine Contraceptive Devices Sales Value by Category (2016-2021)
      • 3.2.3 Global Intra-Uterine Contraceptive Devices Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Intra-Uterine Contraceptive Devices Market Status by End User/Segment

    • 4.1 Intra-Uterine Contraceptive Devices Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Gynaecology Clinics
      • 4.1.3 Community Healthcare
    • 4.2 Global Intra-Uterine Contraceptive Devices Market by End User/Segment
      • 4.2.1 Global Intra-Uterine Contraceptive Devices Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Intra-Uterine Contraceptive Devices Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Intra-Uterine Contraceptive Devices Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Intra-Uterine Contraceptive Devices Market Status by Region

    • 5.1 Global Intra-Uterine Contraceptive Devices Market by Region
      • 5.1.1 Global Intra-Uterine Contraceptive Devices Sales Volume by Region
      • 5.1.2 Global Intra-Uterine Contraceptive Devices Sales Value by Region
    • 5.2 North America Intra-Uterine Contraceptive Devices Market Status
    • 5.3 Europe Intra-Uterine Contraceptive Devices Market Status
    • 5.4 Asia Pacific Intra-Uterine Contraceptive Devices Market Status
    • 5.5 Central & South America Intra-Uterine Contraceptive Devices Market Status
    • 5.6 Middle East & Africa Intra-Uterine Contraceptive Devices Market Status

    6 North America Intra-Uterine Contraceptive Devices Market Status

    • 6.1 North America Intra-Uterine Contraceptive Devices Market by Country
      • 6.1.1 North America Intra-Uterine Contraceptive Devices Sales Volume by Country (2016-2021)
      • 6.1.2 North America Intra-Uterine Contraceptive Devices Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Intra-Uterine Contraceptive Devices Market Status

    • 7.1 Europe Intra-Uterine Contraceptive Devices Market by Country
      • 7.1.1 Europe Intra-Uterine Contraceptive Devices Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Intra-Uterine Contraceptive Devices Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Intra-Uterine Contraceptive Devices Market Status

    • 8.1 Asia Pacific Intra-Uterine Contraceptive Devices Market by Country
      • 8.1.1 Asia Pacific Intra-Uterine Contraceptive Devices Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Intra-Uterine Contraceptive Devices Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Intra-Uterine Contraceptive Devices Market Status

    • 9.1 Central & South America Intra-Uterine Contraceptive Devices Market by Country
      • 9.1.1 Central & South America Intra-Uterine Contraceptive Devices Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Intra-Uterine Contraceptive Devices Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Intra-Uterine Contraceptive Devices Market Status

    • 10.1 Middle East & Africa Intra-Uterine Contraceptive Devices Market by Country
      • 10.1.1 Middle East & Africa Intra-Uterine Contraceptive Devices Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Intra-Uterine Contraceptive Devices Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Intra-Uterine Contraceptive Devices Manufacturing Cost Analysis
    • 11.5 Intra-Uterine Contraceptive Devices Sales Channel and Distributors Analysis
      • 11.5.1 Intra-Uterine Contraceptive Devices Sales Channel
      • 11.5.2 Intra-Uterine Contraceptive Devices Distributors
    • 11.6 Intra-Uterine Contraceptive Devices Downstream Major Buyers

    12 Global Intra-Uterine Contraceptive Devices Market Forecast by Category and by End User/Segment

    • 12.1 Global Intra-Uterine Contraceptive Devices Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Intra-Uterine Contraceptive Devices Forecast by Category
      • 12.2.1 Global Intra-Uterine Contraceptive Devices Sales Volume Forecast by Category
      • 12.2.2 Global Intra-Uterine Contraceptive Devices Sales Value Forecast by Category
      • 12.2.3 Global Intra-Uterine Contraceptive Devices Price Forecast by Category
    • 12.3 Global Intra-Uterine Contraceptive Devices Forecast by End User/Segment
      • 12.3.1 Global Intra-Uterine Contraceptive Devices Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Intra-Uterine Contraceptive Devices Sales Value Forecast by End User/Segment
      • 12.3.3 Global Intra-Uterine Contraceptive Devices Price Forecast by End User/Segment

    13 Global Intra-Uterine Contraceptive Devices Market Forecast by Region/Country

    • 13.1 Global Intra-Uterine Contraceptive Devices Market Forecast by Region (2022-2027)
      • 13.1.1 Global Intra-Uterine Contraceptive Devices Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Intra-Uterine Contraceptive Devices Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Zheijang Daji Medical Instruments, Ltd.
      • 14.1.1 Company Information
      • 14.1.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.1.3 Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teva Pharmaceuticals Industries
      • 14.2.1 Company Information
      • 14.2.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.2.3 Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 SMB Corporation and Meril Life Sciences Pvt. Ltd.
      • 14.3.1 Company Information
      • 14.3.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.3.3 SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Sanghai Jolly Medical Education Co., Ltd
      • 14.4.1 Company Information
      • 14.4.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.4.3 Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Pregna International Limited
      • 14.5.1 Company Information
      • 14.5.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.5.3 Pregna International Limited Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Ocon Medical Ltd.
      • 14.6.1 Company Information
      • 14.6.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.6.3 Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Nimble International
      • 14.7.1 Company Information
      • 14.7.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.7.3 Nimble International Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Mona Lisa N.V.
      • 14.8.1 Company Information
      • 14.8.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.8.3 Mona Lisa N.V. Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Melbea AG
      • 14.9.1 Company Information
      • 14.9.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.9.3 Melbea AG Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Medu Scientific Ltd, China RH Contraceptives Co., Ltd
      • 14.10.1 Company Information
      • 14.10.2 Intra-Uterine Contraceptive Devices Product Introduction
      • 14.10.3 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Medical Engineering Corporation SA
    • 14.12 Injeflex Ind And Com Ltda
    • 14.13 Egemen International
    • 14.14 DKT International
    • 14.15 Contraceptivos
    • 14.16 Cepeo
    • 14.17 Bersil
    • 14.18 Bernstein Leibhard LLP
    • 14.19 Bayer AG
    • 14.20 Amed
    • 14.21 AME Line, Technico

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Intra-Uterine Contraceptive Devices market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Intra-Uterine Contraceptive Devices market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Copper IUCD
      Hormonal IUCD

      Segmented by End User/Segment
      Hospitals
      Gynaecology Clinics
      Community Healthcare

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Zheijang Daji Medical Instruments, Ltd.
      Teva Pharmaceuticals Industries
      SMB Corporation and Meril Life Sciences Pvt. Ltd.
      Sanghai Jolly Medical Education Co., Ltd
      Pregna International Limited
      Ocon Medical Ltd.
      Nimble International
      Mona Lisa N.V.
      Melbea AG
      Medu Scientific Ltd, China RH Contraceptives Co., Ltd
      Medical Engineering Corporation SA
      Injeflex Ind And Com Ltda
      Egemen International
      DKT International
      Contraceptivos
      Cepeo
      Bersil
      Bernstein Leibhard LLP
      Bayer AG
      Amed
      AME Line, Technico
      Buy now